蔡建強(qiáng)，1962年生，籍貫吉林，中國(guó)醫(yī)學(xué)科學(xué)院腫瘤醫(yī)院腹部腫瘤外科專業(yè)，主任醫(yī)師，博士生導(dǎo)師。1980年考入白求恩醫(yī)科大學(xué)臨床醫(yī)學(xué)專業(yè)，1985年獲得學(xué)士學(xué)位。1985年進(jìn)入中國(guó)醫(yī)學(xué)科學(xué)院腫瘤醫(yī)院腹部外科工作，1998年晉升為副主任醫(yī)師，2003年晉升為主任醫(yī)師。1994年08月-1995年05月在德國(guó)海涅大學(xué)血管外科中心訪問學(xué)習(xí)，2000年08月-2001年08月在日本熊本大學(xué)醫(yī)學(xué)部第一外科做訪問學(xué)者。2013年獲中央黨校國(guó)際政治專業(yè)碩士學(xué)位。

致力于腹部惡性腫瘤（原發(fā)性肝癌、結(jié)直腸癌肝轉(zhuǎn)移、軟組織肉瘤、神經(jīng)內(nèi)分泌腫瘤及胃腸間質(zhì)瘤等）以外科治療為主的綜合治療及轉(zhuǎn)化醫(yī)學(xué)研究。建立并倡導(dǎo)“穩(wěn)、準(zhǔn)、輕、快、狠”的手術(shù)安全體系；踐行并推廣MDT理念。

爆草黑丝美女|韩国19禁无遮挡啪啪无码网站|91精品国产自产精品男人的天堂|sm鞭打高潮喷水抽搐调教玩弄|果冻在线|日本大尺度吃奶呻吟视频|久久久久黄片|北条麻妃av免费观看|中文字幕一区二区人妻|亚洲最大天堂无码精品区,日韩 欧美 国产精品,国产肉丝袜在线观看,最爽无遮挡行房视频,成人H视频在线观看,糖心vlog冉冉,蜜桃产品一二三产区

1. Qichen Chen#, Rui Zhang#, Baocai Xing#, Cong Li#, Dianrong Xiu#, Jinghua Chen, Yiqiao Deng, Xiao Chen, Rui Guo, Fenglin Chen, Jianhong Peng, Tao Sun, Hangyan Wang, Muxing Li, Qiwen Zheng, Xinyu Bi, Jianjun Zhao, Jianguo Zhou, Zhiyu Li, Zhen Huang, Yefan Zhang, Yizhou Zhang, Jianqiang Cai*, Hong Zhao*. Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching study. Int J Surg. 2022;106952. (IF:13.400)

2. Qichen Chen#, Zilin Li#, Jiangyuan Yu, Qing Xie, Haizhen Lu, Yiqiao Deng, Jinghua Chen, Wenjia Zhu, Li Huo, Yizhou Zhang, Wei Song, Jianqiang Lan, Jianqiang Cai*, Zhen Huang*, Zixi Wang* & Hong Zhao*. Novel gold nanoparticles targeting somatostatin receptor subtype two with near-infrared light for neuroendocrine tumour therapy. Nano Research.2022;15:9149–9159. (IF:10.269)

3. Wen Zhang#, Caifeng Gong#, Xuenan Peng, Xinyu Bi, Yongkun Sun, Jianguo Zhou, Fan Wu, Huiying Zeng, Yan Wang, Hui Zhou, Hong Zhao*, Jianqiang Cai*, Aiping Zhou*. Serum Concentration of CD137 and Tumor Infiltration by M1 Macrophages Predict the Response to Sintilimab plus Bevacizumab Biosimilar in Advanced Hepatocellular Carcinoma Patients. Clin Cancer Res.2022;28(16):3499-3508. (IF:13.801)

4. Juxian Sun#, Rongping Guo#, Xinyu Bi#, Mengchao Wu, Zhaoyou Tang, Wan Yee Lau, Shusen Zheng, Xuehao Wang, Jinming Yu, Xiaoping Chen, Jia Fan, Jiahong Dong , Yongjun Chen, Yunfu Cui, Chaoliu Dai, Chihua Fang, Shuang Feng, Zhili Ji, Weidong Jia, Ningyang Jia, Gong Li, Jing Li, Qiu Li, Jiangtao Li, Tingbo Liang, Lianxin Liu, Shichun Lu, Yi Lv, Yilei Mao, Yan Meng, Zhiqiang Meng, Feng Shen, Jie Shi, Huichuan Sun, Kaishan Tao, Gaojun Teng, Xuying Wan, Tianfu Wen, Liqun Wu, Jinglin Xia, Mingang Ying, Jian Zhai, Leida Zhang, Xuewen Zhang, Zhiwei Zhang, Haiping Zhao, Donghai Zheng, Xuting Zhi, Jie Zhou, Cuncai Zhou, Jian Zhou, Zhaochong Zeng, Kangshun Zhu, Minshan Chen*, Jianqiang Cai*, Shuqun Cheng*. Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition). Liver Cancer.2022;11(4):315-328. (IF:12,430)

5. Yongkun Sun#, Wen Zhang#, Xinyu Bi#, Zhengqiang Yang#, Yu Tang#, Liming Jiang#, Feng Bi, Minshan Chen, Shuqun Cheng, Yihebali Chi, Yue Han, Jing Huang, Zhen Huang , Yuan Ji, Liqun Jia, Zhichao Jiang, Jing Jin, Zhengyu Jin, Xiao Li, Zhiyu Li, Jun Liang, Lianxin Liu, Yunpeng Liu, Yinying Lu, Shichun Lu, Qinghua Meng, Zuoxing Niu, Hongming Pan, Shukui Qin, Wang Qu, Guoliang Shao, Feng Shen, Tianqiang Song, Yan Song, Kaishan Tao, Aiping Tian, Jianhua Wang, Wenling Wang, Zhe Wang, Liqun Wu, Feng Xia, Baocai Xing, Jianming Xu, Huadan Xue, Dong Yan, Lin Yang, Jianming Ying, Jingping Yun, Zhaochong Zeng, Xuewen Zhang, Yanqiao Zhang, Yefan Zhang, Jianjun Zhao, Jianguo Zhou, Xu Zhu, Yinghua Zou, Jiahong Dong, Jia Fan, Wan Yee Lau, Yan Sun, Jinming Yu, Hong Zhao*, Aiping Zhou*, Jianqiang Cai*. Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements. Liver Cancer.2022;11(3):192-208. (IF:12,430)

6. Jianyang Wang#, Hong Zhao#, Jing Yu#, Xin Xu, Hao Jing, Ning Li, Yuan Tang, Shulian Wang, Yexiong Li, Jianqiang Cai*, Jing Jin*. MiR-320b/RAD21 axis affects hepatocellular carcinoma radiosensitivity to ionizing radiation treatment through DNA damage repair signaling. Cancer Sci.2021;112(2):575-588.(IF:6.716)

7. Shuqun Cheng#*, Minshan Chen#*, Jianqiang Cai#*, Juxian Sun, Rongping Guo, Xinyu Bi, Wan Yee Lau, Mengchao Wu. Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition). Liver Cancer.2020;9(1):28-40. (IF:11.740)

8. Yihebali Chi#, Zhiwei Fang, Xiaonan Hong, Yang Yao, Ping Sun, Guowen Wang, Feng Du, Yongkun Sun, Qiong Wu, Guofan Qu, Shusen Wang, Jianmin Song, Jianchun Yu, Yongkui Lu, Xia Zhu, Xiaohui Niu, Zhiyong He, Jinwan Wang, Hao Yu, Jianqiang Cai*. Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma. Clin Cancer Res.2018;24(21):5233-5238. (IF:8.911 F1000)

9. Fanxin Zeng#, Xiao Chen#, Weiyi Cui#, Wei Wen, Fujian Lu, Xueting Sun, Dongwei Ma, Ye Yuan, Zezhong Li, Ning Hou, Hong Zhao, Xinyu Bi, Jianjun Zhao, Jianguo Zhou, Yan Zhang, Rui-Ping Xiao, Jianqiang Cai*, Xiuqin Zhang*. RIPK1 Binds MCU to Mediate Induction of Mitochondrial Ca²⁺ Uptake and Promotes Colorectal Oncogenesis. Cancer Res.2018;78(11):2876-2885.(IF:8.378)

10. Meng Li#, Hong Zhao#, Xiaosong Zhang, Laura D Wood, Robert A Anders, Michael A Choti, Timothy M Pawlik, Hubert D Daniel, Rajesh Kannangai, G Johan A Offerhaus, Victor E Velculescu, Linfang Wang, Shibin Zhou, Bert Vogelstein, Ralph H Hruban, Nick Papadopoulos, Jianqiang Cai*, Michael S Torbenson* & Kenneth W Kinzler*. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet.2011;43(9):828-9. (IF:35.532 C100)